148 filings
S-8
TRVI
Trevi Therapeutics Inc
20 Mar 24
Registration of securities for employees
4:12pm
10-K
2023 FY
TRVI
Trevi Therapeutics Inc
Annual report
20 Mar 24
4:10pm
8-K
TRVI
Trevi Therapeutics Inc
20 Mar 24
Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates
4:08pm
10-Q
2023 Q3
TRVI
Trevi Therapeutics Inc
Quarterly report
9 Nov 23
4:13pm
8-K
TRVI
Trevi Therapeutics Inc
9 Nov 23
Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Update
4:08pm
EFFECT
1ty48fb5rb0
16 Aug 23
Notice of effectiveness
12:15am
CORRESP
iq2xmy df
14 Aug 23
Correspondence with SEC
12:00am
8-K
n5rd10lku2qvdxdsxrph
10 Aug 23
Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update
4:08pm
UPLOAD
6b7yt
5 Jul 23
Letter from SEC
12:00am
8-K
mjk6h8252
29 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:02pm
S-8
utbcurojdx
11 May 23
Registration of securities for employees
4:16pm
8-K
cqene57zeh uax
11 May 23
Trevi Therapeutics Announces First Quarter 2023 Financial Results and Provides Business Update
4:09pm
ARS
oigcj
1 May 23
Annual report to shareholders
4:03pm
DEFA14A
53sxn fjw2n
1 May 23
Additional proxy soliciting materials
4:03pm
PRE 14A
771u0fhk09e03bxyeo
14 Apr 23
Preliminary proxy
4:26pm